DIA 2016 52nd Annual Meeting

26 June 2016

DIA 2016 was the largest global interdisciplinary event that brought together key thought leaders and innovators from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations from around the globe - and across all disciplines involved in the discovery, development, and life cycle management of health care products.

The goal of the DIA Annual Meeting is to provide you and your team with a rare opportunity to build on what you already know in the development of new therapies and accelerate efforts to enhance health and well-being. Where else can you meet with people from around the world, share your views and knowledge, experience cross-functional content with real-world application from top speakers in the industry, and network with peers to build new relationships across multiple disciplines?

Learning objectives

At the conclusion of DIA 2016, participants are able to:

  • Compare the current regional regulatory and public policy environment pertaining to pharmaceuticals and related products
  • Discuss the regulatory and economic factors that impact the global biopharmaceutical industry
  • Recognize the challenges facing regulatory agencies and industry in research study design and statistical methodology
  • Identify relevant data, document, and systems standards and integration approaches; explain their impact on quality and end-to-end efficiency in data collection, management, submission,and approval processes for medical products
  • Describe the current and future scope of innovative technology, including wearables and other mobile devices, in the generation and collection of electronic source data in clinical research and post-market assessment to improve patient outcomes
  • Discuss the role of big data and analytics, their applications throughout the product life cycle, and their ethical, legal, and security implications for patient data
  • Identify legal, advertising, and marketing issues related to providing product information
  • Apply principles of risk assessment and management to development and post-market phases of new health care products
  • Summarize issues in safety reporting and data analysis regarding adverse events
  • Distinguish regional approaches to integration of evidence-based medicine and comparative effectiveness research into health care decision making
  • Describe current issues in designing and implementing clinical trials, including patient recruitment, site selection, and management of multi-regional clinical trials
  • Identify current opportunities and challenges in the area of personalized medicine for disease treatment
  • Examine ways to provide appropriate support to the clinical trial process that will ultimately impact patient care 


Pennsylvania Convention Center

1101 Arch Street

Philadelphia, PA 19107



Amplexor Life Sciences Booth setup